Molina Healthcare, Inc.
- Open
- 228.61
- Day high
- 231.00
- Day low
- 225.00
- Prev close
- 229.54
- Volume
- 1.0M
- Mkt cap
- $11.9B
- P/E (TTM)
- 67.5
- EPS (TTM)
- $3.39
- P/B
- 2.9
- P/S
- 0.3
- Yield
- —
- Per share
- —
- ▼Insiders net selling -$3.4M over the last 3 months (0 open-market buys, 2 sales)
- 🏛Institutions mixed (13F)
Molina Healthcare, Inc. (MOH) is a Healthcare company listed on NYSE. The stock is down 25% over the past year. Over the trailing 3 months, insiders filed 0 open-market buys and 2 sales (SEC Form 4). Drillr has 1 published research article covering MOH.
Molina Healthcare, Inc. (MOH) financials & analyst ratings
Fundamentals (TTM)
Analyst consensus · 9 analysts
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
MOH earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 23, 2026 | $1.57 | $2.35 | +49.7% | $10.8B | -0.7% |
| Feb 5, 2026 | $0.43 | $-2.75 | -739.5% | $11.4B | +1.3% |
| Oct 22, 2025 | $3.97 | $1.84 | -53.7% | $11.5B | +1.7% |
| Jul 23, 2025 | $5.62 | $5.48 | -2.5% | $11.4B | +4.3% |
| Apr 23, 2025 | $5.97 | $6.08 | +1.8% | $11.1B | +2.8% |
| Feb 5, 2025 | $5.74 | $5.05 | -12.0% | $10.5B | +2.1% |
| Oct 23, 2024 | $5.81 | $6.01 | +3.4% | $10.3B | +4.3% |
| Jul 24, 2024 | $5.50 | $5.86 | +6.5% | $9.9B | +1.2% |
| Feb 7, 2024 | $4.35 | $4.38 | +0.7% | $9.0B | +8.1% |
| Oct 25, 2023 | $4.88 | $5.05 | +3.5% | $8.5B | +3.7% |
| Jul 26, 2023 | $5.10 | $5.65 | +10.8% | $8.3B | +0.9% |
| Feb 8, 2023 | $4.06 | $4.10 | +1.0% | $8.2B | +4.5% |
MOH insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 15, 2026 | HEBERT MAURICEofficer: Chief Accounting Officer | Sell | 600 | $191.55 |
| May 13, 2026 | Barlow Jeff D.officer: Chief Legal Officer | Sell | 17,811 | $186.12 |
| May 8, 2026 | SOISTMAN FRANCIS S JRdirector | Grant | 170 | $197.44 |
| Apr 2, 2026 | ROMNEY RONNAdirector | Grant | 405 | $135.82 |
| Apr 2, 2026 | BRASIER BARBARA Ldirector | Grant | 405 | $135.82 |
| Apr 2, 2026 | Lockhart Stephen Hdirector | Grant | 405 | $135.82 |
| Apr 2, 2026 | GROHOWSKI LEO Pdirector | Grant | 405 | $135.82 |
| Apr 2, 2026 | ORLANDO STEVEN Jdirector | Grant | 405 | $135.82 |
| Apr 2, 2026 | Schapiro Richard Mdirector | Grant | 405 | $135.82 |
| Apr 2, 2026 | ZORETIC RICHARD Cdirector | Grant | 405 | $135.82 |
| Apr 2, 2026 | WOLF DALE Bdirector | Grant | 405 | $135.82 |
| Mar 13, 2026 | ROMNEY RONNAdirector | Sell | 506 | $146.92 |
| Mar 2, 2026 | Zubretsky Joseph Mdirector, officer: President & CEO | Grant | 66,417 | $145.75 |
| Mar 2, 2026 | Barlow Jeff D.officer: Chief Legal Officer | Tax | 1,638 | $154.05 |
| Mar 2, 2026 | Keim Mark Lowellofficer: Chief Financial Officer | Tax | 2,308 | $154.05 |
Source: MOH SEC Form 4 filings, latest May 15, 2026. For informational purposes only — not investment advice.
See the full MOH insider & 13F page →Molina Healthcare, Inc. company profile
Overview
Molina Healthcare, Inc. (NYSE:MOH) is a managed healthcare company that provides health insurance services primarily to low-income individuals and families through government-sponsored programs. Founded in 1980 by Dr. C. David Molina in Long Beach, California, the company went public in 2003 and has grown to become one of the largest Medicaid managed care organizations in the United States. Today, Molina serves approximately 5.2 million members across 18 states, focusing exclusively on government-sponsored healthcare programs including Medicaid, Medicare, and health insurance marketplace plans.
Business
Molina Healthcare operates as a managed care organization (MCO) in the healthcare insurance industry, specifically focusing on government-sponsored health programs. A managed care organization acts as an intermediary between healthcare providers and patients, contracting with doctors, hospitals, and other medical facilities to provide coordinated care while managing costs and quality outcomes. The company operates through four primary business segments: Medicaid Segment (approximately 80% of revenue): This is Molina's core business, providing health insurance coverage to low-income individuals and families who qualify for Medicaid, the joint federal-state program that provides healthcare coverage to eligible low-income adults, children, pregnant women, elderly adults, and people with disabilities. Medicaid is funded jointly by federal and state governments, with states contracting with private managed care organizations like Molina to administer benefits and coordinate care for enrolled members. Medicare Segment (approximately 12% of revenue): Molina provides Medicare Advantage plans, which are private insurance plans that serve as alternatives to traditional Medicare. The company particularly focuses on dual-eligible special needs plans (D-SNPs), which serve individuals who qualify for both Medicare and Medicaid - typically the most vulnerable and high-need populations requiring coordinated care across multiple health and social services. Marketplace Segment (approximately 7% of revenue): Through the Affordable Care Act (ACA) health insurance marketplaces, Molina offers individual health insurance plans to consumers who don't qualify for employer-sponsored insurance or government programs. These plans are often subsidized by federal premium tax credits for eligible individuals and families. Other Segment (minimal revenue): This includes various smaller programs and administrative services. The managed care model works by receiving fixed monthly premium payments from government agencies (capitation payments) and then coordinating and paying for all necessary medical services for enrolled members, creating financial incentives to provide efficient, preventive care while managing costs.
Competitive moat
Molina Healthcare's competitive moat is moderately strong but faces ongoing challenges typical of the managed care industry. The company's primary competitive advantages stem from its specialized focus and operational expertise in serving low-income, high-acuity populations through government-sponsored programs. This specialization creates barriers to entry, as competitors need significant operational capabilities, regulatory expertise, and cultural competency to effectively serve these complex populations. The company benefits from regulatory barriers and contract duration, as Medicaid and Medicare contracts typically span multiple years and require extensive regulatory approval processes, creating switching costs for states and the federal government. Molina's established provider networks and relationships with safety-net hospitals and community health centers in its markets provide operational advantages and make it difficult for new entrants to quickly establish competitive service delivery. However, the moat faces several vulnerabilities: Rate regulation limits pricing power, as government payers set premium rates through actuarial processes rather than market dynamics. Political and policy risks create uncertainty, as changes in federal or state healthcare policies can significantly impact membership and profitability. The industry experiences intense competition from large national players like Centene, Anthem, and UnitedHealth Group, which have greater scale and resources for technology investments and market expansion. Commoditization pressures exist as managed care services become increasingly standardized, reducing differentiation opportunities. The company also faces margin compression from medical cost inflation and regulatory requirements like minimum medical loss ratios. Additionally, technology disruption and direct contracting models between providers and government payers could potentially bypass traditional managed care organizations, though this remains a longer-term risk given the complexity of coordinating care for vulnerable populations.
Risks & safety
Molina Healthcare demonstrates solid financial stability with adequate liquidity and manageable debt levels, though operating cash flow can be volatile due to timing of government payments. • Liquidity position: Strong cash position of $4.9 billion in cash and short-term investments as of Q1 2025, providing substantial financial flexibility • Debt levels: Moderate debt-to-equity ratio of 0.87, manageable for a healthcare services company with predictable government revenue streams • Solvency risk: Low immediate solvency risk given strong balance sheet and regulated capital requirements for insurance operations • Cash flow volatility: Operating cash flow can fluctuate significantly due to timing of government payments and risk corridor settlements, ranging from negative $224M in Q4 2024 to positive $873M in Q3 2024 • Valuation metrics: Trading at reasonable multiples with P/E ratio of 15.1x and EV/EBITDA of 8.8x, suggesting fair valuation relative to earnings • Regulatory capital: Must maintain minimum capital requirements as a regulated insurance company, providing additional financial stability buffers • Government revenue dependence: High dependence on government payments creates both stability (predictable revenue) and risk (policy changes), but government programs are generally viewed as stable long-term
Recent development
Over the past few years, Molina Healthcare has pursued an aggressive growth through acquisition and contract expansion strategy. The company completed several significant acquisitions including AgeWell and My Choice Wisconsin in 2022, and more recently closed the ConnectiCare acquisition from EmblemHealth for $1.4 billion, expanding its presence in Connecticut and adding approximately $1 billion in annual premium revenue. The company has been highly successful in competitive contract bidding, winning new Medicaid contracts in multiple states including Georgia (estimated $2 billion annual revenue), California, Iowa, Nebraska, and New Mexico. These contract wins have significantly increased Molina's "embedded earnings" - future earnings power from secured contracts - which management estimates grew from $7.75 to $8.65 per share for 2026 and beyond. Molina has strategically focused on expanding its dual-eligible special needs plans (D-SNPs) within Medicare, securing contracts in Ohio, Michigan, Massachusetts, and Idaho. This represents a strategic pivot toward serving the most complex, high-need populations who qualify for both Medicare and Medicaid, which typically offer higher margins and more predictable utilization patterns. The company has navigated the Medicaid redetermination process following the end of pandemic-era continuous enrollment requirements, successfully retaining a significant portion of members while managing the acuity shifts as healthier members disenrolled. Management has also maintained its disciplined approach to the Marketplace business, keeping it small and stable at around 7% of revenue while targeting mid-single-digit pre-tax margins. Looking forward, Molina has set ambitious growth targets, projecting premium revenue growth from $40.7 billion in 2024 to $42 billion in 2025, $46 billion in 2026, and $52 billion in 2027, representing a compound annual growth rate of approximately 13-15%. The company continues to actively pursue additional M&A opportunities while maintaining operational discipline around medical cost management and margin targets.
MOH company profile · for informational purposes only — not investment advice.
Track MOH with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free